Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Thrombosis Research|May 11, 2016
PO-24 - Determinants of thrombin generation in gynaecological malignanciesL A Norris, F A Martin, S A O'Toole, et al.
Gynecologic Oncology|October 10, 2006
Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?S A O'Toole, B L Sheppard, A Laios, et al.
Thrombosis Research|September 16, 2021
Extended thromboprophylaxis post gynaecological cancer surgery; the effect of weight adjusted and fixed dose LMWH (Tinzaparin)F Abu Saadeh, Z Marchocki, S A O'Toole, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002
von Willebrand's disease: an important cause of dysfunctional uterine bleedingY L Woo, B White, R Corbally, et al.
British Journal of Clinical Pharmacology|April 28, 1999
Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal womenY Wen, M C Doyle, L A Norris, et al.
Thrombosis Research|February 27, 2016
Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapyF Abu Saadeh, R Langhe, D M Galvin, et al.
Pageof 12